First Time Loading...
M

Molecure SA
WSE:MOC

Watchlist Manager
Molecure SA
WSE:MOC
Watchlist
Price: 14.22 PLN -0.42% Market Closed
Updated: May 8, 2024
Section:
 

Wall Street
Price Targets

MOC Price Targets Summary
Molecure SA

Wall Street analysts forecast MOC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOC is 26.11 PLN with a low forecast of 25.86 PLN and a high forecast of 26.88 PLN.

MOC Lowest Forecast
Wall Street Target
25.86 PLN
82% Upside
MOC Average Forecast
Wall Street Target
26.11 PLN
84% Upside
MOC Highest Forecast
Wall Street Target
26.88 PLN
89% Upside
Lowest
Price Target
25.86 PLN
82% Upside
Average
Price Target
26.11 PLN
84% Upside
Highest
Price Target
26.88 PLN
89% Upside
Molecure SA Competitors:
Price Targets
N
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
22% Upside
S
4565
Sosei Group Corp
51% Upside
4554
Fuji Pharma Co Ltd
27% Upside
R
000650
Renhe Pharmacy Co Ltd
96% Upside
N
603707
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
22% Upside
S
4565
Sosei Group Corp
51% Upside
4554
Fuji Pharma Co Ltd
27% Upside
R
000650
Renhe Pharmacy Co Ltd
96% Upside
G
512
Grand Pharmaceutical Group Ltd
68% Upside
S
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
37% Downside
Z
002332
Zhejiang Xianju Pharmaceutical Co Ltd
27% Upside
INVA
Innoviva Inc
1% Downside

Revenue
Forecast

Revenue Estimate
Molecure SA

For the last 5 years the compound annual growth rate for Molecure SA's revenue is 206%. The projected CAGR for the next 3 years is 116%.

206%
Past Growth
116%
Estimated Growth
Estimates Accuracy
-100%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Molecure SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Molecure SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

See Also

Summary
MOC intrinsic value, competitors valuation, and company profile.
DCF Valuation
MOC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MOC stock valuation using valuation multiples.
Wall Street Estimates
MOC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MOC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOC's stock price target?
Price Target
26.11 PLN

According to Wall Street analysts, the average 1-year price target for MOC is 26.11 PLN with a low forecast of 25.86 PLN and a high forecast of 26.88 PLN.

What is Molecure SA's Revenue forecast?
Projected CAGR
116%

For the last 5 years the compound annual growth rate for Molecure SA's revenue is 206%. The projected CAGR for the next 3 years is 116%.

ALPHA SPREAD
Join more than 135,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.